Results 31 to 40 of about 10,576 (193)

UHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method

Scientia Pharmaceutica, 2018
Perindopril arginine and Indapamide hemihydrate in combination were proven to have a synergistic antihypertensive impact when compared with the use of each component alone.
Naser F. Al-Tannak
doaj   +1 more source

Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats

Saudi Pharmaceutical Journal, 2020
Renin-angiotensin system exerted deleterious effects on learning and cognitive functions through different mechanisms. The present study has been designed to evaluate the protective effect of perindopril and azilsartan as monotherapy or in combination on
Yahya M. Alzahrani, Mai A. Alim A. Sattar, Fatemah O. Kamel, Wafaa S. Ramadan, Yahya A. Alzahrani   +4 more
doaj   +1 more source

▾ More ace inhibitors – quinapril, perindopril & ramipril

, 1991
During 1990 quinapril (Accupro – Parke-Davis), perindopril (Coversyl – Servier) and ramipril (Tritace – Hoechst) joined captopril, enalapril and lisinopril1, 2as inhibitors of angiotensin-converting enzyme (ACE) for the treatment of hypertension.

core   +1 more source

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed, Ahmed Tehemar, Mohamed Gasimelseed, Ahmed Gharaibeh, Muhammad Abdul Hadi, Kazeem Yusuff, Amani Zidan, Ahmed Awaisu   +7 more
wiley   +1 more source

Preparat złożony atorwastatyna/perindopril — nowoczesna prewencja zdarzeń sercowo-naczyniowych [PDF]

, 2019
Cardiovascular diseases are the leading cause of death in Poland. The most common cardiovascular risk factors are dyslipidemia and hypertension. Unfortunately, the percentage of patients with well-controlled dyslipidemia and hypertension remains very low.
Wożakowska-Kapłon, Beata, Gorczyca, Iwona; I Klinika Kardiologii i Elektroterapii, Świętokrzyskie Centrum Kardiologii w Kielcach, ul. Grunwaldzka 45, 25–736 Kielce, Poland   +1 more
core  

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL [PDF]

, 2015
Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone, Russia) and the original perindopril (Prestarium A, Laboratories Servier, France). Material and methods.
A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva, A. I. Malyhina, M. V. Zhuravleva   +4 more
core   +1 more source

Efficacy of Flaxseed Compared to ACE Inhibition in Treating Anthracycline- and Trastuzumab-Induced Cardiotoxicity

CJC Open
Background: Although the current combination of surgery, radiation, and chemotherapy is used in the breast-cancer setting, the administration of the anticancer drugs doxorubicin and trastuzumab is associated with an increased risk of developing heart ...
Sara M. Telles-Langdon, BKin (Hons), MSc, Vibhuti Arya, BSc (Hons), MSc, Paris R. Haasbeek, David Y.C. Cheung, BSc, Cameron R. Eekhoudt, BSc, MSc, Lana Mackic, BSc, Ashley N. Bryson, BSc, MD, Sonu S. Varghese, BSc, MSc, J. Alejandro Austria, James A. Thliveris, PhD, Harold M. Aukema, PhD, Amir Ravandi, MD, PhD, FRCPC, Pawan K. Singal, PhD, DSc, LLD (Hon), Davinder S. Jassal, MD, FACC, FCCS, FRCPC   +13 more
doaj   +1 more source

Perindopril

, 2006
europepmc   +2 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Integrative Approaches in Cardiovascular Disease: The Role of Nutraceuticals in Heart Failure, Atrial Fibrillation, and Related Conditions

Phytotherapy Research, EarlyView.
Schematic representation of the shared pathophysiological mechanisms underlying heart failure (HF) and atrial fibrillation (AF), including inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The figure highlights the clinical and mechanistic convergence of conventional pharmacological therapies and selected nutraceuticals in ...
Laura Beatrice Mattioli, Ivan Corazza, Roberta Budriesi, Luca Camarda, Maria Carelli, Alberto Spadotto, Igor Diemberger   +6 more
wiley   +1 more source